Deciphera Pharmaceuticals, Inc. (DCPH) earnings
Quarterly and annual DCPH reports and results, each read against the price at its own news timestamp. Back to the DCPH overview →
4 measured DCPH earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Deciphera Pharmaceutical For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -0.16% | |
| Form 10-K Deciphera Pharmaceutical For: Dec 31 | SEC filing · Form 10-K | -1.34% | -5.97% | |
| Deciphera Pharmaceuticals Announces Third Quarter 2023 Financial Results | Press release | -1.88% | +4.56% | |
| Form 10-Q Deciphera Pharmaceutical For: Sep 30 | SEC filing · Form 10-Q | -1.88% | +4.56% |
Keep exploring
More DCPH: analyst actions → · SEC filings → · DCPH overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Champions Oncology, Inc. (CSBR) | 130 | +0.20% | 53% |
| INNATE PHARMA (IPHYF) | 130 | 0.00% | 0% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 129 | -0.18% | 44% |
| Medicenna Therapeutics Corp (MDNA_TSE) | 127 | 0.00% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.